Design Therapeutics, Inc.
DSGN
$10.30
-$0.74-6.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.00M | -17.00M | -19.08M | -17.72M | -13.65M |
| Total Depreciation and Amortization | 156.00K | 155.00K | 152.00K | 159.00K | 149.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.92M | 2.82M | 3.50M | 2.48M | 2.03M |
| Change in Net Operating Assets | 960.00K | 2.86M | 994.00K | -1.71M | 1.61M |
| Cash from Operations | -11.97M | -11.16M | -14.44M | -16.79M | -9.86M |
| Capital Expenditure | -34.00K | 0.00 | -87.00K | -72.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.55M | 6.51M | 20.20M | 7.94M | 1.83M |
| Cash from Investing | -11.58M | 6.51M | 20.12M | 7.87M | 1.83M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 25.32M | 37.00K | 361.00K | 23.00K | 263.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.32M | 37.00K | 361.00K | 23.00K | 263.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.77M | -4.62M | 6.04M | -8.90M | -7.77M |